Akil Merchant

Interests in Cancer, Immunotherapy, Lymphoma, CART, Bone Marrow Transplantation and spatial profiling of tumor microenvironment.

[Qasim Rashid, Esq. @QasimRashid]

If Zohran Mamdani becomes NYC mayor at the age of 33 it will be a death blow to millions of young south Asian men in this country.

Every desi parent is gonna be like, “Zohran was Mayor of New York City at 33! You haven’t even bought a house yet! Why can’t you be more like him?!?”

Ohhhh dark days ahead for south Asian men. Smh.

[CancerNetwork® @CancerNetwrk]

In the third or later lines of treatment for those with R/R LBCL, LYL314 led to an ORR of 88% and a CR rate of 72%, with 71% of those patients remaining in a CR for 6 or more months. #lymsm

https://t.co/osORQZHnW9

[Michael Green, PhD @GreenLymphoLab]

Lymphoma Microenvironment Archetype Profiles (LymphoMAPs). Just presented by @dgermain21 at #18icml @icmlugano, now available online in Cancer Cell. #lmsm @washumedicine @MDAndersonNews.
https://t.co/bA2BuZfEFI

[Robert Nelsen @rtnarch]

Lyell far ahead of JNJ and Kite CD19/20, many more patients, treating an apparently much sicker group, showing longer durability, looks like favorable tox. The days of CD19 alone are over. CD19/20 wins, and JNJ, KITE are behind. (ARCH was the first venture backer of Carl June and Juno Therapeutics.)

[Akil Merchant @AkilMerchantMD]

Hey @elonmusk and @VivekGRamaswamy, single payer health care is clearly the most efficient. Love to see DOGE promote that. Time to cut out the insurance companies and pharmacy benefit managers who just suck money and effort out of the system.

[Jason H. Moore, PhD @moorejh]

Cedars-Sinai Establishes Health Sciences University including new PhD Program in Health Artificial Intelligence! Please RT! https://t.co/jZf4ak2TrS #artificialintelligence

[Maryam Kazerani @KazeraniMaryam]

Excited to share that the 2024 Research Updates in Lymphoma was a fantastic success! We enjoyed excellent presentations, insightful discussions, and explored novel techniques and future research opportunities in #lymphoma transformation.
@AkilMerchantMD
@AshAlizadeh

[Joe Schroers-Martin, MD @schroersmartin]

Presenting an overview with Ranjana Advani of the current role of brentuximab and the checkpoint inhibitors in classic Hodgkin lymphoma: https://t.co/S41rWnAZcx Thanks to @JCOOP_ASCO for a great review & publication process.

[Akil Merchant @AkilMerchantMD]

@RongFan8 @MinaXu7 @Halene_lab @ZongmingMa @YaleCancer @YaleEngineering @YaleMed Nicely done. DM me, we should discuss collaborating.

[Akil Merchant @AkilMerchantMD]

@TPP_MD Residents are workers and should be paid for that work. But they are also learners. Some of the pay gap between APP and residents is made up in education and training.

[Akil Merchant @AkilMerchantMD]

@jasonryanmd I get where those students are coming from. Taking care of sick patients is the best part of being a doctor. But for that privilege, sometimes we have to think of service to science or service to the community as the price of that privilege.

[Akil Merchant @AkilMerchantMD]

@RahulBanerjeeMD @lymphomaphilia @btfoundation Why does step 4 lead back to step 1?

[Jason H. Moore, PhD @moorejh]

Are you looking for a PhD program in health AI embedded in a top US hospital with access to clinical data & physicians? Check out our new PhD program at Cedars-Sinai Medical Center in LA https://t.co/8BGZEhpctz #phd #artificialintelligence #Bioinformatics

[Nick Banovich @NeBanovich]

Earlier this week we carried out a preliminary analysis of our first @10xGenomics Xenium prime (5,000 gene) run. We had designed this experiment to get a sense of how the prime chemistry performed compared to the Xenium V1 chemistry.

[Akil Merchant @AkilMerchantMD]

Cell Simulation as Cell Segmentation https://t.co/Yi9IvxDAnm

[Alex Xu @alexmxu_]

We used IMC to look at primary, metastatic, recurrent ovarian cancer - an understudied cancer overall but tissue is widely available.
Side note, published panels are years behind. Can’t speak for all but in this study of ours at least, we can and are doing much better.

[Alex Xu @alexmxu_]

Hello spatial bio folks!

Happy to announce the 2nd Annual Cedars-Sinai Spatial Biology Symposium, next Thursday March 7!

RSVP to join us in LA in person or virtually, for spatial this, spatial that, and all the spatial others!
https://t.co/BmaoiBrpZw

[Jakob Nikolas Kather @jnkath]

Happy to share our latest paper by @ElNahhasOSM et al., which was just published in @NatureComms! This work presents a new method which improves the prediction of biomarkers from routine pathology slides. https://t.co/NPUhaf4tpn @tudresden_de @katherlab @Medizin_TUD

[Cedars-Sinai Academic Medicine @CedarsSinaiMed]

🔬 Have a look at the significant advances Cedars-Sinai Cancer has achieved in enhancing cancer treatment and care. @CSCancerCenter
https://t.co/oUCSOX3AxE

[Stephan Tirier @SMTirier]

A few thoughts on the recent comparison paper for imaging-based #spatialtranscriptomics (iST) methods from the @satijalab:
https://t.co/cuoOqLrqFT